BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11913529)

  • 1. Pharmacological profile of 6,12-dihydro-3-methoxy-1-benzopyrano[3,4-b] [1,4]benzothiazin-6-one, a novel human estrogen receptor agonist.
    Jacquot Y; Cleeren A; Laios I; Yan M; Boulahdour A; Bermont L; Refouvelet B; Adessi G; Leclercq G; Xicluna A
    Biol Pharm Bull; 2002 Mar; 25(3):335-41. PubMed ID: 11913529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substituted benzopyranobenzothiazinones. Synthesis and estrogenic activity on MCF-7 breast carcinoma cells.
    Jacquot Y; Bermont L; Giorgi H; Refouvelet B; Adessi GL; Daubrosse E; Xicluna A
    Eur J Med Chem; 2001 Feb; 36(2):127-36. PubMed ID: 11311744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERE-dependent transcription and cell proliferation: Independency of these two processes mediated by the introduction of a sulfone function into the weak estrogen estrothiazine.
    Jacquot Y; Spaggiari D; Schappler J; Lesniewska E; Rudaz S; Leclercq G
    Eur J Pharm Sci; 2017 Nov; 109():169-181. PubMed ID: 28754571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.
    Kuiper GG; Lemmen JG; Carlsson B; Corton JC; Safe SH; van der Saag PT; van der Burg B; Gustafsson JA
    Endocrinology; 1998 Oct; 139(10):4252-63. PubMed ID: 9751507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERα dimerization: a key factor for the weak estrogenic activity of an ERα modulator unable to compete with estradiol in binding assays.
    Leclercq G; Laïos I; Elie-Caille C; Leiber D; Laurent G; Lesniewska E; Tanfin Z; Jacquot Y
    J Recept Signal Transduct Res; 2017 Apr; 37(2):149-166. PubMed ID: 27400858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
    Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways.
    Li X; Huang J; Yi P; Bambara RA; Hilf R; Muyan M
    Mol Cell Biol; 2004 Sep; 24(17):7681-94. PubMed ID: 15314175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element.
    Kostelac D; Rechkemmer G; Briviba K
    J Agric Food Chem; 2003 Dec; 51(26):7632-5. PubMed ID: 14664520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor beta isoforms exhibit differences in ligand-activated transcriptional activity in an estrogen response element sequence-dependent manner.
    Ramsey TL; Risinger KE; Jernigan SC; Mattingly KA; Klinge CM
    Endocrinology; 2004 Jan; 145(1):149-60. PubMed ID: 14500565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of estrogen- and thyroid hormone receptors on a progesterone receptor estrogen response element (ERE) sequence: a comparison with the vitellogenin A2 consensus ERE.
    Scott RE; Wu-Peng XS; Yen PM; Chin WW; Pfaff DW
    Mol Endocrinol; 1997 Oct; 11(11):1581-92. PubMed ID: 9328341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terpenoids found in the umbelliferae family act as agonists/antagonists for ER(alpha) and ERbeta: differential transcription activity between ferutinine-liganded ER(alpha) and ERbeta.
    Ikeda K; Arao Y; Otsuka H; Nomoto S; Horiguchi H; Kato S; Kayama F
    Biochem Biophys Res Commun; 2002 Feb; 291(2):354-60. PubMed ID: 11846412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding analysis of the estrogen receptor to its specific DNA target site in human breast cancer.
    Foster BD; Cavener DR; Parl FF
    Cancer Res; 1991 Jul; 51(13):3405-10. PubMed ID: 2054780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A three-tiered approach for calibration of a biosensor to detect estrogen mimics.
    Andres SA; Kerr DA; Bumpus SB; Kruer TL; Thieman JW; Smolenkova IA; Wittliff JL
    Adv Exp Med Biol; 2008; 614():305-13. PubMed ID: 18290341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells.
    Chang M; Peng KW; Kastrati I; Overk CR; Qin ZH; Yao P; Bolton JL; Thatcher GR
    Endocrinology; 2007 Oct; 148(10):4793-802. PubMed ID: 17584965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of xenobiotics with estrogen receptors alpha and beta and a putative plasma sex hormone-binding globulin from channel catfish (Ictalurus punctatus).
    Gale WL; Patiño R; Maule AG
    Gen Comp Endocrinol; 2004 May; 136(3):338-45. PubMed ID: 15081833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-mobility group (HMG) protein HMG-1 and TATA-binding protein-associated factor TAF(II)30 affect estrogen receptor-mediated transcriptional activation.
    Verrier CS; Roodi N; Yee CJ; Bailey LR; Jensen RA; Bustin M; Parl FF
    Mol Endocrinol; 1997 Jul; 11(8):1009-19. PubMed ID: 9212049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
    Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
    Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen activates the high-density lipoprotein receptor gene via binding to estrogen response elements and interaction with sterol regulatory element binding protein-1A.
    Lopez D; Sanchez MD; Shea-Eaton W; McLean MP
    Endocrinology; 2002 Jun; 143(6):2155-68. PubMed ID: 12021179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity.
    Ruh MF; Zacharewski T; Connor K; Howell J; Chen I; Safe S
    Biochem Pharmacol; 1995 Oct; 50(9):1485-93. PubMed ID: 7503800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.